Moderna is rising its Covid-19 vaccine production this yr, upping the minimum variety of doses it expects to make by 20% to 600 million, the corporate introduced Monday.
The firm mentioned it's working to produce up to 1 billion doses of its Covid-19 vaccine this yr. The U.S. is on monitor to safe 100 million doses of Moderna's vaccine by the tip of March and extra 100 million by June, the Massachusetts-based firm mentioned in a press release.
The U.S. Food and Drug Administration granted Moderna's Covid-19 vaccine emergency authorization for individuals 18 and older the United States in December and has began the drug's preliminary roll-out.
The federal authorities has agreed to purchase 200 million doses of Moderna's vaccine with the choice to safe an extra 300 million doses, the corporate mentioned.
This is a growing story. Please examine again later for updates.
based mostly on website supplies www.cnbc.com